CRA was retained on behalf of a pharmaceutical manufacturer whose products encountered manufacturing issues following a move of manufacturing facilities to a new geographic area. CRA assessed the change in circumstances and assisted counsel in developing statistical methods by which to assess manufacturing outcomes. CRA also provided damages assessments for class action litigation regarding the manufacturing issues, which were ultimately settled.
Life Sciences Litigation Insights: March 2022
Carl Washington et al. v. CVS Pharmacy Inc., Northern District of California, No. 4:15-vc-19-03504 On June 23, 2021 a federal jury in northern California...